Andrew Booth - Jun 9, 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Financial Officer
Signature
/s/ Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Jun 9, 2021
Transactions value $
-$30,600,000
Form type
4
Date filed
6/10/2021, 05:00 PM
Previous filing
Jun 9, 2021
Next filing
Nov 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Sale -$30.6M -1.2M -100% $25.50 0 Jun 9, 2021 Direct F1
holding ABCL Common Shares 117K Jun 9, 2021 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.